Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.75
  • 52 Week Low: 2.88
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 52,926
  • Market Cap: £8.19m
  • RiskGrade: 429
  • Beta: 0.22

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Lorenzo Gallon, James Renwick McCullough, Erik Kristian Lium

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 3.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.75
52 Week Low 2.88
Volume 52,926
Shares Issued 242.54m
Market Cap £8.19m
Beta 0.22
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.41% below the market average41.41% below the market average41.41% below the market average41.41% below the market average41.41% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Price Trend
89.76% below the market average89.76% below the market average89.76% below the market average89.76% below the market average89.76% below the market average
83.67% below the sector average83.67% below the sector average83.67% below the sector average83.67% below the sector average83.67% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 22-Nov-2024

Time Volume / Share Price
16:03 2,500 @ 3.33p
14:42 50,000 @ 3.47p
11:42 110 @ 3.32p
08:44 316 @ 3.48p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page